1,1-dichloroethene increases expression ISO RGD:1323765 6480464 vinylidene chloride results in increased expression of AXL mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1323765 6480464 1, 2-Dimethylhydrazine results in increased expression of AXL mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1323765 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AXL mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of AXL mRNA CTD PMID:25380136 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1323764 6480464 Tetrachlorodibenzodioxin results in increased expression of AXL mRNA CTD PMID:12377990 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of AXL mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AXL mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323765 6480464 Tetrachlorodibenzodioxin affects the expression of AXL mRNA CTD PMID:21570461 , PMID:28922406 2-butoxyethanol decreases expression ISO RGD:1323765 6480464 n-butoxyethanol results in decreased expression of AXL mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-dichloroaniline decreases expression ISO RGD:1323764 6480464 3, 4-dichloroaniline results in decreased expression of AXL mRNA CTD PMID:24172598 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of AXL mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1323765 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of AXL mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1323765 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of AXL mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1323765 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of AXL exon CTD PMID:33297965 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1323765 6480464 Oxazolone results in increased expression of AXL mRNA CTD PMID:11379042 5-aza-2'-deoxycytidine affects expression ISO RGD:1323764 6480464 Decitabine affects the expression of AXL mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1323764 6480464 [Decitabine results in decreased methylation of AXL gene] which results in increased expression of AXL CTD PMID:18522535 7,12-dimethyltetraphene increases expression ISO RGD:1323764 6480464 9 more ... CTD PMID:21527772 acetamide increases expression EXP 6480464 acetamide results in increased expression of AXL mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1323765 6480464 Acrylamide results in increased expression of AXL mRNA CTD PMID:30807115 actinomycin D increases expression ISO RGD:1323764 6480464 Dactinomycin results in increased expression of AXL mRNA CTD PMID:21527772 adefovir pivoxil increases expression ISO RGD:1323764 6480464 adefovir dipivoxil results in increased expression of AXL mRNA CTD PMID:25596134 ADP decreases response to substance ISO RGD:1323764 6480464 AXL protein results in decreased susceptibility to Adenosine Diphosphate CTD PMID:15733062 aflatoxin B1 increases expression ISO RGD:1323764 6480464 Aflatoxin B1 results in increased expression of AXL mRNA, Aflatoxin B1 results in increased expression of AXL protein CTD PMID:21527772 , PMID:21641981 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of AXL mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:1323764 6480464 Aflatoxin B1 results in increased methylation of AXL gene CTD PMID:27153756 Aflatoxin B2 alpha decreases methylation ISO RGD:1323764 6480464 aflatoxin B2 results in decreased methylation of AXL exon CTD PMID:30157460 all-trans-retinoic acid multiple interactions ISO RGD:1323765 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of AXL mRNA CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AXL mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:1323764 6480464 aristolochic acid I results in increased expression of AXL mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1323764 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AXL mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1323764 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AXL mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:1323764 6480464 arsenite inhibits the reaction [G3BP1 protein binds to AXL mRNA] CTD PMID:32406909 benzo[a]pyrene multiple interactions ISO RGD:1323765 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to AXL promoter] CTD PMID:19654925 benzo[a]pyrene affects methylation ISO RGD:1323764 6480464 Benzo(a)pyrene affects the methylation of AXL exon CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1323764 6480464 Benzo(a)pyrene results in decreased methylation of AXL promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1323764 6480464 Benzo(a)pyrene results in increased expression of AXL mRNA CTD PMID:21632981 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1323764 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene decreases methylation ISO RGD:1323764 6480464 benzo(e)pyrene results in decreased methylation of AXL exon CTD PMID:30157460 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1323764 6480464 Diethylhexyl Phthalate results in increased expression of AXL mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AXL mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AXL mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:1323764 6480464 bisphenol A results in decreased expression of AXL mRNA CTD PMID:29718440 bisphenol F multiple interactions ISO RGD:1323765 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of AXL mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of AXL mRNA CTD PMID:24136188 cadmium dichloride increases expression ISO RGD:1323764 6480464 Cadmium Chloride results in increased expression of AXL mRNA CTD PMID:25596134 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of AXL mRNA CTD PMID:25993096 cannabidiol increases expression ISO RGD:1323765 6480464 Cannabidiol results in increased expression of AXL mRNA CTD PMID:30742662 capecitabine decreases response to substance ISO RGD:1323764 6480464 AXL protein results in decreased susceptibility to Capecitabine CTD PMID:16734730 carbamazepine affects expression ISO RGD:1323764 6480464 Carbamazepine affects the expression of AXL mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1323765 6480464 Nanotubes, Carbon analog results in increased expression of AXL mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1323765 6480464 Nanotubes, Carbon analog results in decreased expression of AXL mRNA CTD PMID:25620056 chlordecone increases expression ISO RGD:1323765 6480464 Chlordecone results in increased expression of AXL mRNA CTD PMID:29980752 chloroacetaldehyde affects expression ISO RGD:1323764 6480464 chloroacetaldehyde affects the expression of AXL mRNA CTD PMID:25596134 cidofovir anhydrous increases expression ISO RGD:1323764 6480464 Cidofovir results in increased expression of AXL mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:1323765 6480464 Cisplatin results in increased expression of AXL mRNA CTD PMID:21151649 cisplatin increases expression ISO RGD:1323764 6480464 Cisplatin results in increased expression of AXL mRNA CTD PMID:16061661 , PMID:25596134 cisplatin affects expression ISO RGD:1323764 6480464 Cisplatin affects the expression of AXL mRNA CTD PMID:23300844 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of AXL mRNA CTD PMID:22023808 clodronic acid increases expression ISO RGD:1323764 6480464 Clodronic Acid results in increased expression of AXL mRNA CTD PMID:25596134 clofibrate increases expression ISO RGD:1323765 6480464 Clofibrate results in increased expression of AXL mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1323764 6480464 cobaltous chloride results in increased expression of AXL mRNA CTD PMID:17553155 cobalt dichloride decreases expression ISO RGD:1323764 6480464 cobaltous chloride results in decreased expression of AXL mRNA CTD PMID:17553155 , PMID:19320972 copper atom multiple interactions ISO RGD:1323764 6480464 [NSC 689534 binds to Copper] which results in increased expression of AXL mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1323764 6480464 [NSC 689534 binds to Copper] which results in increased expression of AXL mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1323764 6480464 Copper Sulfate results in increased expression of AXL mRNA CTD PMID:19549813 CU-O LINKAGE decreases expression ISO RGD:1323764 6480464 cupric oxide results in decreased expression of AXL mRNA CTD PMID:22077320 cyclophosphamide increases expression ISO RGD:1323764 6480464 Cyclophosphamide results in increased expression of AXL mRNA CTD PMID:21527772 cyclosporin A decreases expression ISO RGD:1323764 6480464 Cyclosporine results in decreased expression of AXL mRNA CTD PMID:25596134 , PMID:27989131 cyclosporin A increases expression ISO RGD:1323764 6480464 Cyclosporine results in increased expression of AXL mRNA CTD PMID:25562108 cytarabine decreases expression ISO RGD:1323764 6480464 Cytarabine results in decreased expression of AXL mRNA CTD PMID:21198554 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of AXL mRNA CTD PMID:21266533 dioxygen increases expression ISO RGD:1323764 6480464 Oxygen deficiency results in increased expression of AXL mRNA CTD PMID:25596134 diuron decreases expression EXP 6480464 Diuron results in decreased expression of AXL mRNA CTD PMID:25152437 diuron decreases expression ISO RGD:1323764 6480464 Diuron metabolite results in decreased expression of AXL mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1323764 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AXL mRNA CTD PMID:27188386 doxifluridine decreases response to substance ISO RGD:1323764 6480464 AXL protein results in decreased susceptibility to doxifluridine CTD PMID:16734730 doxorubicin affects response to substance ISO RGD:1323764 6480464 AXL protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression ISO RGD:1323764 6480464 Doxorubicin results in increased expression of AXL mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:1323765 6480464 Doxorubicin results in increased expression of AXL mRNA CTD PMID:22008532 elemental selenium decreases expression ISO RGD:1323764 6480464 Selenium results in decreased expression of AXL mRNA CTD PMID:19244175 epoxiconazole decreases expression ISO RGD:1323765 6480464 epoxiconazole results in decreased expression of AXL mRNA CTD PMID:35436446 erlotinib hydrochloride decreases response to substance ISO RGD:1323764 6480464 AXL results in decreased susceptibility to Erlotinib Hydrochloride CTD PMID:22751098 erlotinib hydrochloride multiple interactions ISO RGD:1323764 6480464 [amuvatinib results in decreased activity of AXL protein] which results in increased susceptibility to Erlotinib Hydrochloride, [GSK 1363089 results in decreased activity of AXL protein] which results in increased susceptibility to Erlotinib Hydrochloride CTD PMID:22751098 ethanol multiple interactions ISO RGD:1323765 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of AXL mRNA CTD PMID:30517762 ethanol increases expression ISO RGD:1323765 6480464 Ethanol results in increased expression of AXL mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1323764 6480464 Ethyl Methanesulfonate results in increased expression of AXL mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:1323764 6480464 Etoposide results in increased expression of AXL mRNA CTD PMID:21527772 fenamidone increases expression ISO RGD:1323765 6480464 fenamidone results in increased expression of AXL mRNA CTD PMID:27029645 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of AXL mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1323765 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AXL mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:1323765 6480464 Folic Acid results in decreased expression of AXL mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of AXL mRNA CTD PMID:27387713 gemcitabine multiple interactions ISO RGD:1323764 6480464 AXL protein promotes the reaction [Warfarin results in increased susceptibility to Gemcitabine] CTD PMID:26206560 hydrogen peroxide multiple interactions ISO RGD:1323765 6480464 AXL protein promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of AKT1 protein] CTD PMID:15123721 hydrogen peroxide increases phosphorylation EXP 6480464 Hydrogen Peroxide results in increased phosphorylation of AXL protein CTD PMID:15123721 hydrogen peroxide multiple interactions EXP 6480464 GAS6 protein promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of AXL protein], Warfarin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of AXL protein] CTD PMID:15123721 ifosfamide increases expression ISO RGD:1323764 6480464 Ifosfamide results in increased expression of AXL mRNA CTD PMID:25596134 Lasiocarpine decreases expression EXP 6480464 lasiocarpine results in decreased expression of AXL mRNA CTD PMID:32419051 leflunomide increases expression ISO RGD:1323764 6480464 leflunomide results in increased expression of AXL mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1323764 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of AXL mRNA more ... CTD PMID:35811015 , PMID:35877022 menaquinone multiple interactions EXP 6480464 Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of AXL protein] CTD PMID:27212383 methapyrilene decreases methylation ISO RGD:1323764 6480464 Methapyrilene results in decreased methylation of AXL exon CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1323764 6480464 Methyl Methanesulfonate results in increased expression of AXL mRNA CTD PMID:21527772 , PMID:23649840 methylparaben decreases expression ISO RGD:1323764 6480464 methylparaben results in decreased expression of AXL mRNA CTD PMID:31745603 mithramycin decreases expression ISO RGD:1323764 6480464 Plicamycin results in decreased expression of AXL CTD PMID:18522535 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AXL gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression ISO RGD:1323764 6480464 1-Methyl-4-phenylpyridinium results in increased expression of AXL mRNA CTD PMID:24810058 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:1323764 6480464 Methylnitronitrosoguanidine results in increased expression of AXL mRNA CTD PMID:12634122 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AXL mRNA CTD PMID:20360939 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of AXL mRNA CTD PMID:24136188 nitric oxide decreases expression ISO RGD:1323765 6480464 Nitric Oxide deficiency results in decreased expression of AXL mRNA CTD PMID:15878706 ozone multiple interactions ISO RGD:1323765 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AXL mRNA CTD PMID:34911549 paclitaxel increases response to substance ISO RGD:1323764 6480464 AXL protein results in increased susceptibility to Paclitaxel CTD PMID:16734730 paracetamol affects expression ISO RGD:1323765 6480464 Acetaminophen affects the expression of AXL mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of AXL mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1323764 6480464 Acetaminophen results in increased expression of AXL mRNA CTD PMID:22230336 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AXL gene CTD PMID:33148267 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AXL mRNA CTD PMID:20360939 phylloquinone multiple interactions EXP 6480464 [Warfarin co-treated with Vitamin K 1] results in decreased expression of AXL protein, Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of AXL protein] CTD PMID:27212383 pirinixic acid decreases expression ISO RGD:1323765 6480464 pirinixic acid results in decreased expression of AXL mRNA CTD PMID:20813756 quercetin increases expression ISO RGD:1323764 6480464 Quercetin results in increased expression of AXL mRNA CTD PMID:21632981 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1323764 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of AXL mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1323764 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of AXL mRNA CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:1323765 6480464 Buthionine Sulfoximine results in increased expression of AXL mRNA CTD PMID:15878706 SB 431542 multiple interactions ISO RGD:1323764 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AXL mRNA CTD PMID:27188386 selenium atom decreases expression ISO RGD:1323764 6480464 Selenium results in decreased expression of AXL mRNA CTD PMID:19244175 serpentine asbestos increases expression ISO RGD:1323764 6480464 Asbestos, Serpentine results in increased expression of AXL mRNA CTD PMID:29523930 silicon dioxide increases expression ISO RGD:1323764 6480464 Silicon Dioxide analog results in increased expression of AXL mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1323765 6480464 Silver results in increased expression of AXL mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1323765 6480464 Silver results in increased expression of AXL mRNA CTD PMID:27131904 simvastatin decreases expression ISO RGD:1323764 6480464 Simvastatin results in decreased expression of AXL mRNA CTD PMID:17428261 sodium arsenate increases expression ISO RGD:1323765 6480464 sodium arsenate results in increased expression of AXL mRNA CTD PMID:30953684 sodium arsenate multiple interactions ISO RGD:1323764 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AXL mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1323764 6480464 sodium arsenite results in increased expression of AXL mRNA CTD PMID:29301061 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of AXL protein CTD PMID:12644472 sunitinib decreases expression ISO RGD:1323764 6480464 Sunitinib results in decreased expression of AXL mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:1323764 6480464 T-2 Toxin results in increased expression of AXL mRNA CTD PMID:34581912 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of AXL mRNA CTD PMID:12734012 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of AXL mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1323765 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of AXL mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:1323765 6480464 Carbon Tetrachloride results in increased expression of AXL mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of AXL protein CTD PMID:16799993 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AXL mRNA CTD PMID:34492290 toluene 2,4-diisocyanate decreases expression ISO RGD:1323765 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of AXL mRNA CTD PMID:11379042 Tributyltin oxide increases expression ISO RGD:1323765 6480464 bis(tri-n-butyltin)oxide results in increased expression of AXL mRNA CTD PMID:18958704 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of AXL mRNA CTD PMID:30589522 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1323764 6480464 tris(2-butoxyethyl) phosphate affects the expression of AXL mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:1323765 6480464 troglitazone results in increased expression of AXL mRNA CTD PMID:28973697 urethane decreases expression ISO RGD:1323764 6480464 Urethane results in decreased expression of AXL mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1323765 6480464 Valproic Acid affects the expression of AXL mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1323764 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AXL mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1323764 6480464 Valproic Acid results in decreased expression of AXL mRNA CTD PMID:24383497 more ... vancomycin decreases expression ISO RGD:1323765 6480464 Vancomycin results in decreased expression of AXL mRNA CTD PMID:18930951 vincaleukoblastine affects response to substance ISO RGD:1323764 6480464 AXL protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of AXL mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:1323764 6480464 Vitamin E results in decreased expression of AXL mRNA CTD PMID:19244175 vitamin K multiple interactions ISO RGD:1323764 6480464 Vitamin K inhibits the reaction [Warfarin results in decreased expression of AXL protein modified form] CTD PMID:26206560 vitamin K increases expression ISO RGD:1323764 6480464 Vitamin K results in increased expression of AXL protein modified form CTD PMID:26206560 warfarin multiple interactions EXP 6480464 [Warfarin co-treated with Vitamin K 1] results in decreased expression of AXL protein more ... CTD PMID:15123721 , PMID:27212383 warfarin decreases phosphorylation ISO RGD:1323764 6480464 Warfarin results in decreased phosphorylation of AXL protein CTD PMID:26206560 warfarin increases response to substance ISO RGD:1323764 6480464 AXL protein results in increased susceptibility to Warfarin CTD PMID:26206560 warfarin multiple interactions ISO RGD:1323764 6480464 AXL protein promotes the reaction [Warfarin results in increased susceptibility to Gemcitabine] more ... CTD PMID:26206560 warfarin decreases expression ISO RGD:1323764 6480464 Warfarin results in decreased expression of AXL protein, Warfarin results in decreased expression of AXL protein modified form CTD PMID:26206560 zoledronic acid decreases expression ISO RGD:1323764 6480464 zoledronic acid results in decreased expression of AXL mRNA CTD PMID:24714768 , PMID:25596134